Special Situations: Valeant Pharmaceuticals Public “Private Equity” Restructuring

Valeant Pharmaceuticals Special Situations: Public "Private Equity" Restructuring August 13, 2016 SUMMARY INFO Recent PPS: $24.92 Shares Out: 355 million Market Cap: $8,847 Net Debt: $30,085 Enterprise: $38,932 DISCUSSION ***Disclosure: This is a distressed, leveraged special situation trade with only the potential to turn into a medium- to long-term investment.*** I have been involved/followed the … Continue reading Special Situations: Valeant Pharmaceuticals Public “Private Equity” Restructuring

Advertisements